Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure
- 1 June 1994
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 343 (8912), 1519-1522
- https://doi.org/10.1016/s0140-6736(94)92935-1
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins.JCI Insight, 1992
- Radioreceptor assay for advanced glycosylation end productsDiabetes, 1991
- Advanced Glycosylation End Products in Patients with Diabetic NephropathyNew England Journal of Medicine, 1991
- Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes.JCI Insight, 1991
- End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen.JCI Insight, 1990
- Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties.The Journal of Experimental Medicine, 1989
- Cachectin/TNF and IL-1 Induced by Glucose-Modified Proteins: Role in Normal Tissue RemodelingScience, 1988
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsNew England Journal of Medicine, 1988
- Relation between Complications of Type I Diabetes Mellitus and Collagen-Linked FluorescenceNew England Journal of Medicine, 1986